CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM NEW
Total 13F shares
4,845,815
Share change
-2,109,349
Total reported value
$14,394,051
Put/Call ratio
342%
Price per share
$2.97
Number of holders
56
Value change
-$6,765,984
Number of buys
18
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q2 2021

As of 30 Jun 2021, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,845,815 shares. The largest 10 holders included VANGUARD GROUP INC, SEGALL BRYANT & HAMILL, LLC, ROYCE & ASSOCIATES LP, Penbrook Management LLC, PERKINS CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Tibra Equities Europe Ltd, and AMERIPRISE FINANCIAL INC. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.